Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Haas Jason received 836 Ligand Pharmaceuticals Incorporated shares as an award (Form 4)
Traded Jun 5, 2026 · Filed Jun 9, 2026
On Jun 5, 2026, Haas Jason (Director) received 836 Ligand Pharmaceuticals Incorporated shares as an award, leaving 7,442 shares. Filed Jun 9, 2026 (Form 4).
- Awarded
- 836 shares
- Holding after
- 7,442 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | Award | 836 | 7,442 | Direct |
Source
Related
- Ligand Pharmaceuticals Incorporated
- Haas Jason
- Ligand Pharmaceuticals Incorporated shareholders
- Form 4 · Haas Jason · Aug 14, 2026
- Form 4 · Haas Jason · Jun 15, 2026
- Form 4 · Reardon Andrew · Oct 6, 2026
- Form 4 · Zimmermann Martine · Sep 24, 2026
- Form 4 · Zimmermann Martine · Sep 14, 2026
- Form 4 · Reardon Andrew · Sep 8, 2026
- Form 4 · Espinoza Octavio · Aug 14, 2026